Skip to main content
SpringerLink
Log in

Micro and Nanoparticles as Drug Carriers

  • Chapter
NBC Risks Current Capabilities and Future Perspectives for Protection

Part of the book series: NATO Science Series ((ASDT,volume 25))

  • 189 Accesses

Abstract

For effective therapy with medication, it is necessary to deliver therapeutic agents selectively to their target sites, since most drugs are associated with both beneficial effects and unfavorable actions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Puisieux F., Barratt G., Roblot-Treupel L., Delattre J., Couvreur P.C. and Devissaguet J.P. Therapeutic aspects of liposomes. In Phospholipids: Biochemical, Pharmaceutical and Analytical Considerations, I. Hanin and G. Pepeu (eds.), Plenum Press, New York, pp 133–165

    Google Scholar 

  2. Tomlinson E., Davis S.S. (1986) (eds.): Site-specific drug delivery, John Wiley & Sons, Chichester

    Google Scholar 

  3. Juliano R.L. (1991) (ed.): Targeted drug delivery, Springer-Verlag, Berlin

    Google Scholar 

  4. Gupta P.K. (1990) Drug targeting in cancer chemotherapy: a clinical perspective, J. Pharm. Sci.,79, 949–962

    Article  PubMed  CAS  Google Scholar 

  5. Couvreur P., Dubernet C., Puisieux F. (1995) Controlled drug delivery with nanoparticles: current possibilities and future trends. Eur.J. Pharm. Biopharm., 41, 2–13

    CAS  Google Scholar 

  6. Okada H., Toguchi H. (1995) Biodegradable microspheres in drug delivery. Crit.Rev.Ther.Drug Carr.Syst., 12, 1–99

    Article  CAS  Google Scholar 

  7. Kreuter J. (1994) (ed.)Colloidal drug delivery systems, M. Dekker, New York, pp 73–190

    Google Scholar 

  8. Leucuta S.E. (1987) Pharmaceutical systems for controlled delivery and drug targeting (in Romanian), Editura Medicala, Bucuresti, pp 1–179

    Google Scholar 

  9. Leucuta S.E. (1996) Targeted drugs (in Romanian), Editura Medicala, Bucuresti, pp 1–293

    Google Scholar 

  10. Puisieux F., Barrati G., Benita S., Couarraze G., Couvreur P., Devissaguet J.P., Dubernet C., Fattal E., Fessi H., Vauthier C. (1991) Polymeric micro and nanoparticles as drug carriers. In Polymeric biomaterials; S. Dumitriu, M. Szycher (eds.), M. Dekker

    Google Scholar 

  11. Tomlinson E. (1983) Microsphere delivery systems for drug targeting and controlled release. Int. J. Pharm. Jech. Prod. Mfr., 4, 49–57

    CAS  Google Scholar 

  12. Davis S.S., Ilium L. (1986) Colloidal delivery systems: opportunities and challenges. In Site-specific drug delivery, E. Tomlinson, S.S. Davis (eds.), John Wiley & Sons, Chichester, pp 93–110

    Google Scholar 

  13. Friend D.R., Pangburn S. (1987) Site — specific drug delivery. Medicinal Res. Rev., 7, 53–106

    Article  CAS  Google Scholar 

  14. Leucuta S.E. (1986) Controlled release of metronidazole from gelatin microspheres and ethylcellulose coated microcapsules and kinetics of drug release. Clujul Medical, 59, 346–352

    CAS  Google Scholar 

  15. Leucuta S.E. (1986) Magnetic microspheres and microcapsules as carriers for intravascular admionistration of metronidazole. Drug Dev.Ind.Pharm., 2281–2288

    Google Scholar 

  16. Leucuta S.E. (1989) The kinetics of in vitro release and pharmacokinetics of miotic response in rabbits of gelatin and albumin microspheres with pilocarpine. Int. J. Pharm., 54, 71–78

    Article  CAS  Google Scholar 

  17. Leucuta S.E., Risca R., Daicoviciu D., Porutiu D. (1988) Albumin microspheres as a drug delivery system for epirubicin: pharmaceutical, pharmacokinetic and biological aspects. Int. J. Pharm., 41, 213–217

    Article  CAS  Google Scholar 

  18. Leucuta S.E. (1990) Controlled release of nifedipine from gelatin microspheres and microcapsules: in vitro kinetics and pharmacokinetics in man. J. Microencapsulation, 7, 209–217

    Article  PubMed  CAS  Google Scholar 

  19. Leucuta S.E., Porutiu D., Polinicencu M. (1987) Microspheres and microcapsules adriamycin loaded: preparation and in vitro release kinetics (in Romanian): Farmacia, 35, 133–138

    Google Scholar 

  20. Couvreur P., Roland M., Speiser P. (1982) Biodegradable submicroscopic particles containing a biologically active substance and compositions containing them. US Patent Nr. 4, 329, 332

    Google Scholar 

  21. Magenheim B., Benita S. (1991) Nanoparticle characterization: a comprehensive physicochemical approach. S.T.P. Pharma Sciences, 1, 221–241

    CAS  Google Scholar 

  22. Kreuter J. (1983) Evaluation of nanoparticles as drug delivery systems. I. Preparation methods. Pharm.Acta Helv., 58, 196–209

    CAS  Google Scholar 

  23. Bornschein M., Melegari P., Bismarck C., Keipert S. (1990) Micro and nanoparticles a carrier systems with special consideration on the preparation methods. Pharmazie, 44, 585–593

    Google Scholar 

  24. Achim M., Leucuta S.E. (1997) Preparation and in vitro characterization of gelatin microspheres epirubicin loaded. Farmacia (Bucharest), 45, (2), 45–52

    CAS  Google Scholar 

  25. Achim M., Leucuta S.E. (1997) Adsorption of epirubicin on polymethacrylate microspheres and in vitro release kinetics. Farmacia, 45, (4), 61–68

    CAS  Google Scholar 

  26. Washington C. (1990) Drug release from microdisperse systems. A critical review. Int. J. Pharm., 58, 1–12

    Article  CAS  Google Scholar 

  27. Lu D.R., Abu-Izza K., Mao F. (1996) Nonlinear data fitting for controlled release devices: an integrated computer program. Int. J. Pharm., 129, 243–251

    Article  CAS  Google Scholar 

  28. Miron M., Demeter F., Preda M., Bodea A., S.E. Leucuta (1997) Preparation and characterization of some biodegradable microspheres with antibiotics. Farmacia (Bucharest), 45, 37–44

    CAS  Google Scholar 

  29. Achim M., Ghizdavu L., Leucuta S.E. (1997) Doxorubicin loaded gelatin microspheres: preparation and physicochemical evaluation (in Romanian). Clujul Medical, 70, 482–487

    CAS  Google Scholar 

  30. Leucuta S.E., Risca R., Daicoviciu D., Porutiu D. (1987) Pharmacokinetic study of adriamycin in serum, lungs and heart after the administration of a single intravenous dose in rats as albumin microspheres (in Romanian). Oncologia, 26, 41–50

    CAS  Google Scholar 

  31. Leucuta S.E., Risca R., Daicoviciu D. (1987) The influence of the administration of a single intravenous dose of gelatin microspheres metronidazole loaded, on the lungs pharmacokinetics of the drug (in Romanim):Farmacia, 35, 119–126

    CAS  Google Scholar 

  32. Achim M., Risca R., Postescu D., Leucuta S.E. (1998) Pharmacokinetics of tissue distribution of epirubicin-loaded liposomes and nanoparticles in rats. 2nd World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Paris, May 1998 (accepted).

    Google Scholar 

  33. Risca R., Daicoviciu D., Leucuta S.E., Berindan I., Crisan M., Madriz L. (1993) Biologic effects of the antitumoral treatment with epirubicin free or incorporated in gelatin microspheres (in Romanian). Cancerul, (serie noua), 1, 3–10

    Google Scholar 

  34. Daicoviciu D., Risca R., Leucuta S.E., Papilian C., Mulea R. (1987) The effect of epirubicin loaded albumin microspheres on the Ehrlich ascites tumor development. Morphology and Embryology, (Bucharest), 33, 291–295

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Faculty of Pharmacy, Department of Pharmaceutical Technology and Biopharmaceutics, University of Medicine and Pharmacy “Iuliu Hatieganu”, Str.Emil Isac nr. 13, 3400, Cluj-Napoca, Romania

    S. E. Leucuta

Authors
  1. S. E. Leucuta
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Studies and Science, German Armed Forces Medical Academy, Munich, Germany

    Torsten Sohns  & Harald Kempf  & 

  2. University of Medicine & Pharmacy ”Carol Davila”, Bucharest, Romania

    Victor A. Voicu

  3. Department of Studies and Science, Institute of Pharmacology and Toxicology, German Armed Forces Medical Academy, Munich, Germany

    Ladislaus Szinicz

  4. Department of Studies and Science, Institute of Microbiology, German Armed Forces Medical Academy, Munich, Germany

    Ernst-Juergen Finke

  5. Army Center of Medical Research and University of Medicine and Pharmacy „Carol Davila“, Bucharest, Romania

    Constantin Mircioiu

  6. Defence Research Establishment Suffield, Box 4000, Medicine Hat, Alberta, TIB 2 P5, Canada

    P. Lundy

  7. An-Ex, Redwood Building, Cf 1 3xF, Cardiff, UK

    Keith R. Brain

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Leucuta, S.E. (1999). Micro and Nanoparticles as Drug Carriers. In: Sohns, T., et al. NBC Risks Current Capabilities and Future Perspectives for Protection. NATO Science Series, vol 25. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-4641-8_33

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-4641-8_33

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-0-7923-5803-9

  • Online ISBN: 978-94-011-4641-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation